Skip to main content
MedChemComm logoLink to MedChemComm
. 2018 Mar 7;9(3):591–592. doi: 10.1039/c8md90011f

Correction: Novel valdecoxib derivatives by ruthenium(ii)-promoted 1,3-dipolar cycloaddition of nitrile oxides with alkynes – synthesis and COX-2 inhibition activity

Silvia Roscales a, Nicole Bechmann a, Daniel Holger Weiss b, Martin Köckerling b, Jens Pietzsch a,c, Torsten Kniess a,
PMCID: PMC6144543  PMID: 30288211

Abstract

Correction for ‘Novel valdecoxib derivatives by ruthenium(ii)-promoted 1,3-dipolar cycloaddition of nitrile oxides with alkynes – synthesis and COX-2 inhibition activity’ by Silvia Roscales et al., Med. Chem. Commun., 2018, DOI: 10.1039/c7md00575j.

The authors regret that the structure of compound 1c in Scheme 4 was not correct. The corrected structure is shown below.

Scheme 4.

Scheme 4

Also, the name of compound 1f was not correct in the Electronic Supplementary Information file. 3-[4-(Methylsulfonyl)phenyl]propioaldehyde has been corrected to 3-[4-(methylsulfonyl)phenyl]prop-2-ynal and the corrected file has been uploaded to replace the original file.

The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.


Articles from MedChemComm are provided here courtesy of Royal Society of Chemistry

RESOURCES